Nanovascular Technologies, Inc.
ActiveNanovascular Technologies builds a noninvasive smart wearable that quantifies edema and vitals to predict heart-failure decompensation early and prevent avoidable hospitalizations.
What it does
Nanovascular Technologies is building a noninvasive smart wearable and clinical dashboard to help health systems and value-based care teams prevent avoidable heart-failure hospitalizations. By continuously quantifying edema alongside key vitals and activity, we detect worsening congestion earlier and generate actionable, clinician-friendly alerts that prompt timely medication adjustments or visits before patients decompensate. Compared with today’s weight checks, symptom calls, and invasive monitors, our approach is lower-friction, scalable, and designed to fit RPM workflows. We’re advancing regulatory and clinical validation and are actively partnering with hospitals, ACOs, and Medicare Advantage groups for pilots and LOIs that convert into enterprise deployments.
Next to it in Healthcare and bio · wearable for cardiac decompensation prediction
- LightHearted AIEntrepreneur First EF London 2023
Noninvasive cardiac screening via wearables.
- KneevoiceTechstars TS 2023
Kneevoice | Innovative Cartilage Auscultation Tool Santa Monica, CA
- Corveus MedicalY Combinator W22
Catheter-based solution to treat chronic heart failure.
- ff-techPlug and Play PnP 2024
Non-Invasive Wearable Continuous Blood Glucose Monitor (NICGM)
- VentriJectPlug and Play PnP 2024
Assessing the most important indicator of health (VO2max) in less than 3 minutes without the use of exercise
- AlveosAntler Antler Finland 2025
Wearable that Listens to Your Breath
- Onalabs Inno-hubPlug and Play PnP 2025
Onalabs is a medical company that now is revolutionizing sports performance by turning sweat into real-time insights — empowering athletes to train smarter, recover faster, and push beyond limits.
- Evolution DevicesAlchemist Accelerator Alchemist Class 25
Electrical Stimulation to Rehabilitate Walking